Nature

hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma

Uterine serous papillary adenocarcinoma (USPC) is a highly aggressive variant of endometrial cancer. Human immuno-conjugate molecule (hI-con1) is an antibody-like molecule targeted against tissue ...
technologynetworks

Laureate and Iconic Announce Immunoprotein Manufacturing Agreement

Laureate Pharma, Inc. has announced that it has entered into a biopharmaceutical manufacturing agreement with Iconic Therapeutics, Inc. for cGMP manufacture of hI-con1, a "bi-functional immunoprotein" ...
Nature

DUF1220 copy number is associated with schizophrenia risk and severity: implications for understanding autism and schizophrenia as related diseases

DNA from 609 individuals diagnosed with schizophrenia using DSM-IV criteria was selected from the NIMH Repository and Genomics Resource and acquired from the cell and DNA repository at Rutgers ...